Cambridge startup analyses ‘multi-omics’ data to discover new heart drugs
Cambridge-based CardiaTec has raised $6.5mn for its AI-based drug discovery platform for cardiovascular diseases.
Continue ReadingWorld Of Magazines And News Articles
Cambridge-based CardiaTec has raised $6.5mn for its AI-based drug discovery platform for cardiovascular diseases.
Continue Reading